TB Alliance on Lotus FM in South Africa
Almari Uys of the TB Alliance was interviewed on Lotus FM Radio in South Africa. Conradie discussed the recent collaboration with the United...
Almari Uys of the TB Alliance was interviewed on Lotus FM Radio in South Africa. Conradie discussed the recent collaboration with the United...
TB Alliance CEO, Dr. Mel Spigelman, was interviewed on Doctor Radio on Sirius. Those who think U.S. residents aren't significantly expo...
(Durban, SOUTH AFRICA,) The TB Alliance today announced the launch of a collaboration with the National Institute of Allergy and Infectious Diseases&r...
· AstraZeneca, Bayer, Sanofi, Tibotec, TB Alliance, and the World Health Organization sign part...
Today, the global health community mourns the loss of Winstone Zulu, an immeasurably brave and tireless advocate for access to medicines and the devel...
The World Health Organization (WHO) reports for the first time that the number of people falling ill with tuberculosis (TB) each year is declining.&nb...
The September 2011 issue of Pharmaceutical Executive featured a cover story on the significant impact global health PDPs are making on the drug develo...
Clofazamine is a drug from the riminophenazine class that was developed in the 1950s for use against leprosy, but which has also shown activity agains...
The TB Alliance and its partners will be presenting recent advances in TB research and development at the ICAAC 2011 conference. Posters and presentat...
Buoyed by the support of the CPTR initiative and its partners, clinical TB drug regimen development efforts are already underway. The TB Alliance rece...